DFFVX
Price
$37.59
Change
-$0.02 (-0.05%)
Updated
Dec 26 closing price
Net Assets
14.08B
RSPYX
Price
$30.96
Change
-$0.03 (-0.10%)
Updated
Dec 26 closing price
Net Assets
584.29M
Interact to see
Advertisement

DFFVX vs RSPYX

Header iconDFFVX vs RSPYX Comparison
Open Charts DFFVX vs RSPYXBanner chart's image
DFA US Targeted Value I
Price$37.59
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets14.08B
Victory RS Partners Y
Price$30.96
Change-$0.03 (-0.10%)
VolumeN/A
Net Assets584.29M
DFFVX vs RSPYX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. RSPYX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RSPYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.1B vs. RSPYX (584M). DFFVX pays higher dividends than RSPYX: DFFVX (1.65) vs RSPYX (0.69). DFFVX was incepted earlier than RSPYX: DFFVX (26 years) vs RSPYX (19 years). RSPYX (1.05) is less costly to investors than DFFVX (0.30). RSPYX is a more actively managed with annual turnover of: 48.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RSPYX: DFFVX (0) vs RSPYX (1000000). DFFVX annual gain was more profitable for investors over the last year : 10.25 vs. RSPYX (-0.93). DFFVX return over 5 years is better than : 69.65 vs. RSPYX (23.14).
DFFVXRSPYXDFFVX / RSPYX
Total Expense Ratio0.290.9431%
Annual Report Gross Expense Ratio0.301.0529%
Fund Existence26 years19 years-
Gain YTD10.992-0.418-2,631%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets14.1B584M2,414%
Annual Yield % from dividends1.650.69240%
Returns for 1 year10.25-0.93-1,106%
Returns for 3 years43.3322.10196%
Returns for 5 years69.6523.14301%
Returns for 10 years99.6115.46644%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBE84.161.03
+1.24%
Invesco Biotechnology & Genome ETF
USXF58.420.16
+0.28%
iShares® ESG Advanced MSCI USA ETF
DDWWF5.65N/A
N/A
Dividend Growth Split Corp.
USOY6.60-0.03
-0.45%
Defiance Oil Enhanced Options Income ETF
NDIA29.97-0.22
-0.72%
Global X India Active ETF